Thioctic acid does not restore glutathione levels or protect against the potentiation of 6-hydroxydopamine toxicity induced by glutathione depletion in rat brain

Journal of Neural Transmission

Volumn 103, Issue 3, 1996, Pages 315-329

  Seaton, T A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

6 OHDA toxicity; Buthionine sulphoximine; Glutathione depletion; Substantia nigra; Thioctic acid

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; BUTHIONINE SULFOXIMINE; DOPAMINE; GLUTATHIONE; OXIDOPAMINE; THIOCTIC ACID; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; ANTIMETABOLITES; BIOGENIC MONOAMINES; BRAIN; BRAIN CHEMISTRY; BUTHIONINE SULFOXIMINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUTATHIONE; IMMUNOHISTOCHEMISTRY; MALE; NEOSTRIATUM; OXIDOPAMINE; RATS; RATS, WISTAR; SYMPATHOLYTICS; THIOCTIC ACID; TYROSINE 3-MONOOXYGENASE;

EID: 0029670509     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf01271243     Document Type: Article

References (12)

1. Anderson ME, Meister A (1989) Marked increase in cysteine levels in many regions of the brain after administration of 2-oxo-4-thiazolidine-carboxylate. FASEB J 3:1632-1636
2. Aw TY, Wierzbicka G, Jones DP (1991) Oral glutathione increases tissue glutathione concentration in vivo. Chem-Biol Interact 80: 89-97
3. Busse E, Zimmer G, Schopohl B, Kornhuber B (1992) Influence of α-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittelforschung 42: 829-831
4. Carman LS, Gage FH, Shutts CW (1991) Partial lesion of the substantia nigra: relation between extent of lesion and rotational behaviour. Brain Res 553: 275-283
5. Cohen G, Heikkila RE (1974) The generation of hydrogen peroxide, superoxide radical and hydroxyl radical by 6-hydroxydopamine, dialuric acid and related cytotoxic agents. J Biol Chem 249: 2447-2452
6. Cohen G, Spina MB (1989) Deprenyl suppresses the oxidant stress associated with increased dopamine turnover. Ann Neurol 26: 689-690
7. Dexter DT, Wells FR, Agid F, Agid Y, Jenner P, Marsden CD (1989) Increased nigral iron content and alterations in other metal ions in brain in Parkinson's disease. J Neurochem 52: 1830-1836
8. Dexter DT, Sian J, Rose S, Hindmarsh JG, Mann VM, Cooper JM, Wells FR, Daniel SE, Lees AJ, Schapira AHV, Jenner P, Marsden CD (1994) Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann Neurol 35: 38-44
9. Ehrenthal W, Preilwitz W (1986) Biochemie und Pharmakologie der Liponsäure. In: Neundörfer B, Sailer D (Hrsg) Interdisziplinäre Bestandsaufnahme der Polyneuropathien. Perimed, Erlangen, S154
10. Götz ME, Dirr A, Burger R, Janetzky B, Weinmüller M, Chan W, Chen S, Reischmann H, Rausch W-D, Riederer P (1994) Effect of lipoic acid on redox state of coenzyme Q in mice treated with l-methyl-4-phenyl-l, 2, 3, 6-tetrahydropyridine and diethyldithiocarbamate. Eur J Pharmacol 266: 291-300
11. Greenamyre JT, Garcia-Osuna M, Greene JG (1994) The endogenous cofactors, thioctic acid and dihydrolipoic acid are neuroprotective against NMDA and malonic acid lesions of striatum. Neurosci Lett 171: 17-20
12. Griffith OW (1982) Mechanism of action, metabolism and toxicity of buthionine sulfoximine and its higher homologues, potent inhibitors of glutathione synthesis. J Biol Chem 257: 13704-13712